Robert E. Waltermire
CIK 1876996 · Senior VP, Chief Pharma Dev. · last filed 2025-03-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.74M
Companies
1
Total Filings
15
Lifetime Open-Market Net
-$11.25M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MDGL | Senior VP, Chief Pharma Dev. | 14,018 | $480.77 | $6.74M | -$11.25M | 15 | 2025-03-07 |
Recent Filings · Page 2 of 2
15 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-12-14 | MDGL | Mixed | — | -$512.6K | EDGAR |
| 2023-03-02 | MDGL | Mixed | — | -$1.85M | EDGAR |
| 2023-01-18 | MDGL | Grant (A) | +5,667 | $0 | EDGAR |
| 2022-02-24 | MDGL | Grant (A) | — | $0 | EDGAR |
| 2021-08-04 | MDGL | Grant (A) | — | $0 | EDGAR |
Showing 11–15 of 15
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.